Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Sinopharm-CICC
investment firm
About
Sinopharm-CICC is a private equity fund focused on investments in the healthcare industry under CICC Capital.
Highlights
Details
- Operating Status
- Active
- Investor Type
- PE
Sinopharm-CICC is a private equity fund focused on investments in the healthcare industry under CICC Capital.
Investments
Number of Investments
Number of Lead Investments
4
1
Sinopharm-CICC has made 4 investments. Their most recent investment was on
Aug 18, 2022, when Zhenge Biotech raised ¥100M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Aug 18, 2022
Zhenge Biotech
|
Series C | ¥100M | Biotechnology | — |
|
Aug 2, 2022
Xingmai Technology
|
Series Unknown | ¥100M | Health Diagnostics | Yes |
|
Oct 6, 2020
Hinova Pharma
|
Series C | ¥1B | Health Care | — |
|
Aug 5, 2020
MicuRx Pharmaceuticals
|
Series D | ¥300M | Biotechnology | — |
Exits
Sinopharm-CICC has had 1 exits. Sinopharm-CICC most notable exits include MicuRx Pharmaceuticals
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Aug 4, 2022 | MicuRx Pharmaceuticals | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
